Search
for
Sort by
Research 91–120 of 776
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Efficacy of tofacitinib in pediatric alopecia universalis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Current and future pharmacotherapy for alopecia areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- A review of Janus kinase inhibitor use in scarring alopecia
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Alopecia Areata
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment